Icon (NASDAQ:ICLR – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 10.000-11.000 for the period, compared to the consensus estimate of 11.330. The company issued revenue guidance of $7.9 billion-$8.2 billion, compared to the consensus revenue estimate of $7.9 billion.
Icon Price Performance
Shares of ICLR traded up $4.60 during mid-day trading on Wednesday, reaching $118.45. The company had a trading volume of 1,759,245 shares, compared to its average volume of 1,582,337. The company’s 50 day simple moving average is $111.14 and its 200 day simple moving average is $141.95. Icon has a 1-year low of $66.57 and a 1-year high of $211.00. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.06 and a current ratio of 1.06. The company has a market capitalization of $9.57 billion, a price-to-earnings ratio of 16.03, a P/E/G ratio of 3.05 and a beta of 1.23.
Wall Street Analyst Weigh In
ICLR has been the topic of a number of research analyst reports. TD Cowen upgraded shares of Icon from a “hold” rating to a “buy” rating and reduced their price target for the company from $183.00 to $120.00 in a research note on Wednesday, February 18th. Zacks Research downgraded shares of Icon from a “hold” rating to a “strong sell” rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. reduced their price target on shares of Icon from $175.00 to $120.00 and set a “neutral” rating on the stock in a research note on Monday, May 18th. Rothschild & Co Redburn set a $100.00 target price on shares of Icon and gave the stock a “neutral” rating in a research report on Tuesday, February 17th. Finally, Weiss Ratings lowered shares of Icon from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 18th. Seven investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $147.67.
Hedge Funds Weigh In On Icon
Several large investors have recently modified their holdings of ICLR. WINTON GROUP Ltd bought a new position in shares of Icon during the second quarter valued at $254,000. Daiwa Securities Group Inc. lifted its position in shares of Icon by 19.3% in the 2nd quarter. Daiwa Securities Group Inc. now owns 28,145 shares of the medical research company’s stock worth $4,094,000 after purchasing an additional 4,546 shares during the period. Frontier Capital Management Co. LLC lifted its position in shares of Icon by 97.6% in the 2nd quarter. Frontier Capital Management Co. LLC now owns 71,360 shares of the medical research company’s stock worth $10,379,000 after purchasing an additional 35,253 shares during the period. Peapack Gladstone Financial Corp acquired a new position in shares of Icon in the 2nd quarter worth approximately $212,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its position in shares of Icon by 58.7% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 781 shares of the medical research company’s stock worth $113,000 after purchasing an additional 289 shares during the period. Institutional investors own 95.61% of the company’s stock.
Icon Company Profile
Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.
Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.
See Also
- Five stocks we like better than Icon
- Abercrombie Rallies as Strong Q1 Earnings Extend Winning Streak
- TeraWulf Bets on Power Infrastructure to Lead AI Build-Out
- Amazon’s Alexa for Shopping Strengthens an Already Strong Bull Case
- Keysight: The AI and Defense Stock Seeing Big Price Target Boosts
Receive News & Ratings for Icon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Icon and related companies with MarketBeat.com's FREE daily email newsletter.
